Literature DB >> 23900598

Claudin 1 expression characterizes human uterine cervical reserve cells.

Balázs Zinner1, Benedek Gyöngyösi, Edit Babarczi, András Kiss, Gábor Sobel.   

Abstract

Stem cells participate in cervical carcinogenesis but their function and exact features are still not clear. One type of stem-like cells are endocervical reserve cells (RCs), and their association with other normal/altered cervical cells is not exactly known. Epithelial cells are attached to each other by tight junctions. Their dominant components are the claudin proteins, which show changed expression in cancer; however, no data are available on their pattern. Expressions of various claudins (1, 2, 3, 4, 7), occludin, cytokeratins 5/6 and 7, and p63 were analyzed in 60 paraffin-embedded cervical samples. Immunohistochemical reactions were evaluated semiquantitatively and statistically. Claudin 1 was as high in RCs as in cervical intraepithelial neoplasia (CIN) and higher than in suprabasal squamous epithelial cells, contrary to the negative glandular and squamous basal cells. Claudin 2 was positive in all cell types except parabasal cells, whereas claudins 4 and 7 were weakly positive and claudin 3 was negative in all cell types. Occludin was positive in RCs, basal/parabasal cells, and CIN, whereas glandular cells were negative. This is a first report that describes the intermediate claudin pattern of RCs, demonstrating that it differs from that of cervical glandular and squamous basal cells, but showing an expression similar to the strong claudin 1 expression detected in cervical neoplastic cells.

Entities:  

Keywords:  claudin 1; reserve cells; tight junction

Mesh:

Substances:

Year:  2013        PMID: 23900598      PMCID: PMC3840739          DOI: 10.1369/0022155413501324

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  30 in total

Review 1.  Junctions gone bad: claudins and loss of the barrier in cancer.

Authors:  Kursad Turksen; Tammy-Claire Troy
Journal:  Biochim Biophys Acta       Date:  2011-04-15

Review 2.  Claudins: multifunctional players in epithelial tight junctions and their role in cancer.

Authors:  S S Oliveira; J A Morgado-Díaz
Journal:  Cell Mol Life Sci       Date:  2007-01       Impact factor: 9.261

3.  Predicted expansion of the claudin multigene family.

Authors:  Katsuhiko Mineta; Yasuko Yamamoto; Yuji Yamazaki; Hiroo Tanaka; Yukiyo Tada; Kuniaki Saito; Atsushi Tamura; Michihiro Igarashi; Toshinori Endo; Kosei Takeuchi; Sachiko Tsukita
Journal:  FEBS Lett       Date:  2011-01-26       Impact factor: 4.124

Review 4.  Molecular basis of the core structure of tight junctions.

Authors:  Mikio Furuse
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

5.  Tricellulin expression in normal and neoplastic human pancreas.

Authors:  Anna Korompay; Katalin Borka; Gábor Lotz; Aron Somorácz; Péter Törzsök; Boglárka Erdélyi-Belle; István Kenessey; Zsolt Baranyai; Fanni Zsoldos; Péter Kupcsulik; György Bodoky; Zsuzsa Schaff; András Kiss
Journal:  Histopathology       Date:  2012-03-06       Impact factor: 5.087

6.  Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma.

Authors:  Gábor Sobel; Csilla Páska; István Szabó; András Kiss; Anna Kádár; Zsuzsa Schaff
Journal:  Hum Pathol       Date:  2005-02       Impact factor: 3.466

7.  Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells.

Authors:  Agnieszka K Witkiewicz; Jonathan L Hecht; Aida Cviko; Frank D McKeon; Tan A Ince; Christopher P Crum
Journal:  Hum Pathol       Date:  2005-02       Impact factor: 3.466

8.  Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.

Authors:  Lilach Kleinberg; Arild Holth; Claes G Trope; Reuven Reich; Ben Davidson
Journal:  Hum Pathol       Date:  2008-05       Impact factor: 3.466

9.  Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Authors:  Y-L Choi; J Kim; M J Kwon; J S Choi; T-J Kim; D-S Bae; S S Koh; Y-H In; Y W Park; S H Kim; G Ahn; Y K Shin
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

Review 10.  Tight junctions at a glance.

Authors:  Maria S Balda; Karl Matter
Journal:  J Cell Sci       Date:  2008-11-15       Impact factor: 5.285

View more
  4 in total

Review 1.  Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions.

Authors:  Ádám Galamb; Márta Benczik; Balázs Zinner; Eszter Vígh; Kornélia Baghy; Csaba Jeney; András Kiss; Gábor Lendvai; Gábor Sobel
Journal:  Pathol Oncol Res       Date:  2015-01-20       Impact factor: 3.201

2.  Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.

Authors:  Masakazu Sato; Kei Kawana; Katsuyuki Adachi; Asaha Fujimoto; Mitsuyo Yoshida; Hiroe Nakamura; Haruka Nishida; Tomoko Inoue; Ayumi Taguchi; Juri Ogishima; Satoko Eguchi; Aki Yamashita; Kensuke Tomio; Osamu Wada-Hiraike; Katsutoshi Oda; Takeshi Nagamatsu; Yutaka Osuga; Tomoyuki Fujii
Journal:  Oncotarget       Date:  2017-06-20

3.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

4.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.